VOYT yields 20000000.00% · PFE yields 6.13%● Live data
📍 VOYT pulled ahead of the other in Year 1
Combined, VOYT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VOYT + PFE for your $10,000?
Voyant International Corp., through its subsidiaries, designs and delivers software technology to accelerate and manage large data transfers over IP networks. Its primary product families include RocketStream data transfer technology, which provides file transfer acceleration, automation, and security functions for market verticals, such as oil and gas, mining, entertainment, legal, financial services, military, and medical; and RocketConnect, a software-based product designed to accelerate data traversing between a telephone switching center and consumer's premises or mobile devices. The company also intends to provide an array of network-based products and services while airborne, including Internet access, email, PDA access, and advertising and multimedia content. In addition, it is developing remotely configurable, broadband radios that operate in the white space portion of the spectrum between VHF and UHF television stations. The company was formerly known as Zeros & Ones, Inc. and changed its name to Voyant International Corp. in April 2007. Voyant International Corp. is based in Hollywood, California.
Full VOYT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.